Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Baek‐Yeol Ryoo | Researchclopedia

Back to researchers

Baek‐Yeol Ryoo

Ulsan College ORCID

497

Works

17,270

Citations

64

h-index

245

i10-index

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis Gastric Cancer Management and Outcomes Pancreatic and Hepatic Oncology Research

Affiliations

Ulsan College2009–2025

Yonsei University2009–2009

Korea University2009–2009

Korea University Medical Center2007–2007

Asan Medical Center2006–2025

Top Works

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

Richard S. Finn,Baek‐Yeol Ryoo,et al.

20191,783 citations

Cholangiocarcinoma and Gallbladder Cancer Studies

Colorectal Cancer Treatments and Studies

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

Andrew X. Zhu,Joon Oh Park,et al.

2015838 citations

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma

Andrew X. Zhu,Alexander R. Abbas,et al.

2022590 citations

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

Michael S. Lee,Baek‐Yeol Ryoo,et al.

2020561 citations

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial

Robin Kate Kelley,Lorenza Rimassa,et al.

2022505 citations

Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion

Sang Min Yoon,Baek‐Yeol Ryoo,et al.

2018445 citations

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet,Masatoshi Kudo,et al.

2023382 citations

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

Yoon‐Koo Kang,Jeong Hwan Yook,et al.

2021341 citations

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa,Shukui Qin,et al.

2018249 citations